Witri Tablet 150 mg (Trimebutine Maleate)

Adult dose

As Trimebutine Maleate, take 100-200 mg orally three times a day before meals. Adjust as appropriate based on age and symptoms.

This medication may affect the gastrointestinal system, and rare symptoms such as constipation, diarrhea, borborygmus (sounds from the abdomen), nausea, vomiting, dyspepsia, dry mouth, and a numb sensation in the mouth may occur. Additionally, it may affect the cardiovascular system, occasionally leading to symptoms like rapid heartbeat. It can also influence the central nervous system, resulting in rare occurrences of fatigue, drowsiness, dizziness, lethargy, and headaches. Liver function could be impacted, potentially causing a temporary increase in liver enzyme levels. Allergic reactions may rarely appear as skin rashes; if such symptoms occur, the medication should be discontinued immediately. The safety of this medication during pregnancy has not been fully established. Therefore, women who are pregnant or could become pregnant should only use it if the benefits of treatment outweigh the risks. Women who are breastfeeding should avoid this medication due to uncertain safety. If it must be taken, it is advisable to stop breastfeeding. This medication contains lactose; therefore, individuals with genetic metabolic disorders such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take it.

Mild side effects

• Constipation
• diarrhea
• borborygmus
• nausea
• vomiting
• dyspepsia
• dry mouth
• numbness in the mouth
• palpitations
• fatigue

Store this medication in a tightly sealed container to prevent air ingress. It is best to keep it at room temperature between 1 degree and 30 degrees Celsius.

Appearance

White round tablets

Package unit

10 tablets/PTP